LRI sponsors high-quality research, published in peer-reviewed journals, and seeks to provide sound scientific advice on which industry and regulatory bodies can draw to respond more quickly and accurately to society’s concerns.
In the context of its LRI programme for 2013, the European Chemical Industry Council (Cefic) is accepting grant applications to carry out research in the following areas:
- LRI-B14: Skin sensitisation - chemical applicability domain of the Local Lymph Node Assay (LLNA)
- LRI-B15: Efficiency of Risk Management Measures (RMM)
- LRI-ECO23: Combining passive sampling and toxicity profiling to assess mixture toxicity of surface waters
- LRI-ECO24: Prediction of Non-Extractable Residues (NER) using structural information
- LRI-ECO25: Development of soup tests for the risk assessment of NER in soil
- LRI-EMSG58: Quality assessment of the epidemiological evidence of adverse effects to humans of endocrine active substances in the environment
- LRI-N4: Grouping nanomaterials and establishing criteria for Safe by Design
- LRI-S3: Benefits and risk evidence streams for decision makers
Further details of each research area can be found by following the links on each topic.
The deadline for applications is 1 September 2013. Project specifications, budget details and application forms can be found on the Cefic LRI website. Only proposals that fit the project specifications and are submitted via the official LRI application form will be considered.
The scientific evaluation and selection of applications for funding are managed by a scientific committee provided by ECETOC. In particular, within LRI, ECETOC has the responsibility of maintaining three “core teams”: health effects, human exposure & risk assessment and environment.
For further information, please read the complete LRI Requests for Proposals on the Cefic LRI website, or contact Dr. Bruno Hubesch, Cefic-LRI Manager, or the LRI Secretariat.